RECURRENT
Clinical trials for RECURRENT explained in plain language.
Never miss a new study
Get alerted when new RECURRENT trials appear
Sign up with your email to follow new studies for RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental combo shows promise for Hard-to-Treat blood cancer
Disease control CompletedThis study tested a new immune-boosting treatment for people with a type of aggressive lymphoma (DLBCL) that came back or didn't respond to standard therapy. 25 adults received a vaccine-like therapy (DPX-Survivac) plus a common chemo drug (cyclophosphamide) and an immunotherapy …
Matched conditions: RECURRENT
Phase: PHASE2 • Sponsor: Sunnybrook Health Sciences Centre • Aim: Disease control
Last updated May 26, 2026 06:45 UTC
-
Gene-Tailored drugs show promise for rare salivary gland cancer
Disease control CompletedThis study looked at whether giving people with advanced salivary gland cancer a drug that matches their tumor's genetic makeup can help control the disease. 114 participants first had their tumor genes analyzed. If a targetable change was found, they got a matched drug; if not, …
Matched conditions: RECURRENT
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Cow colostrum shows promise in stopping Kids' repeat UTIs
Prevention CompletedThis study tested whether a supplement made from bovine colostrum (the first milk from cows) can prevent repeated urinary tract infections (UTIs) in children. Sixty children with a history of recurrent UTIs took part. The goal was to see if this natural supplement could reduce th…
Matched conditions: RECURRENT
Phase: PHASE2 • Sponsor: Ain Shams University • Aim: Prevention
Last updated May 19, 2026 11:59 UTC
-
Hernia surgery showdown: fewer stitches may mean less pain
Symptom relief CompletedThis study looked at 351 adults with inguinal hernia who had keyhole surgery (TAPP). Doctors compared using 3 stitches versus 1 stitch to hold the mesh in place. The goal was to see which method caused less pain, fewer fluid collections (seroma), and fewer hernia comebacks over a…
Matched conditions: RECURRENT
Phase: NA • Sponsor: Nanchong Central Hospital • Aim: Symptom relief
Last updated May 26, 2026 06:45 UTC